AstraZeneca

Category

Volunteer in the AstraZeneca AZD1222 Clinical Trial Dies in Brazil, However, Reports are Death Not Connected to Oxford Vaccine: Trial Apparently to Proceed

Shares of AstraZeneca’s stock declined as a volunteer participating in the Phase 3 clinical trial in Brazil died, reports Brazil’s food and drug regulator Anvisa. According to Reuters’ reports, the national coordinator of the study, the Federal University of Sao...

European Medicines Agency Initiates Rolling Review of AZD1222 While FDA Puts Trial on Hold for a Different Review

The European Medicines Agency (EMA) human medicines committee (CHMP) reports publicly the first ‘rolling review’ of a COVID-19 vaccine starting with AstraZeneca’s AZD1222 or the “Oxford” vaccine. This committee is investigating the first batch of data on the vaccine...

Heroes Step Up: UW Madison Physician the First to Sign up to Participate in AZD1222 Trial at UW Hospital

The University of Wisconsin-Madison (UW Madison) has been selected as one of the first test sites in the country for the large Phase 3 AZD1222 clinical trial, investigating AstraZeneca’s experimental vaccine originally developed by the University of Oxford. Led by...

The AstraZeneca Phase 3 COVID-19 Vaccine Study: Unprecedented Compression of Timeline of Est. Start Date to Est. Primary Completion Date

Is President Trump preparing to fast track the AstraZeneca COVID-19 vaccine known as AZD1222? According to a report in the Financial Times, this is exactly what is being contemplated as the administration would “bypass normal regulatory standards to fast-track”...

MedPharmics Selected by AstraZeneca for Phase 3 COVID-19 Vaccine Trial: First Site in New Mexico to Enroll Soon

MedPharmics LLC, based in Louisiana, has mobilized its Albuquerque, New Mexico trial site location to support a COVID-19 vaccine clinical trial sponsored by AstraZeneca and Oxford University. In fact, this will be the first such site in all of New Mexico to enroll...

Pin It on Pinterest